Pegylated Interferon α-2b, Ribavirin and Amantadine for Chronic Hepatitis C

By Younossi Zobair   McCullough Arthur   Barnes David   Post Anthony   Ong Janus   O’shea Robert   Martin Lisa   Bringman Diane   Farmer Denise   Levinthal Gavin   Mullen Kevin   Carey William   Tavill Anthony   Ferguson Roy   Gramlich Terry  

Digestive Diseases and Sciences, Vol. 50, Iss. 5, 2005-05 ,pp. : 970-975

Springer Publishing Company

Access to resources Recommend Favorite

Late hepatitis B virus relapse in patients co-infected with hepatitis B virus and hepatitis C virus after antiviral treatment with pegylated interferon-a2b and ribavirin

By Potthoff A.   Berg T.   Wedemeyer H.  

Scandinavian Journal of Gastroenterology, Vol. 44, Iss. 12, 2009-12 ,pp. : 1487-1490

Informa Healthcare

Access to resources Recommend Favorite

Pegylated interferon alpha-2a monotherapy in a peritoneal dialysis patient with chronic hepatitis C

By Mimura Imari   Ishibashi Yoshitaka   Tateishi Ryosuke   Kaname Shinya   Fujita Toshiro  

NDT PLUS, Vol. 1, Iss. 4, 2008-08 ,pp. : 233-235

Oxford University Press

Access to resources Recommend Favorite

Sustained Viral Response to Pegylated Interferon α-2b and Ribavirin in Chronic Hepatitis C Refractory to Prior Treatment

By Mathew A.   Peiffer L.   Rhoades K.   McGarrity T.  

Digestive Diseases and Sciences, Vol. 51, Iss. 11, 2006-11 ,pp. : 1956-1961

Springer Publishing Company

Access to resources Recommend Favorite

A case of deep venous thrombosis associated with pegylated interferon α2b plus ribavirin treatment of chronic hepatitis C

By Okuse Chiaki   Adachi Kayo   Katakura Yoshiki   Matsunaga Kotaro   Ishii Toshiya   Matsumoto Nobuyuki   Yotsuyanagi Hiroshi   Iino Shiro   Suzuki Michihiro   Itoh Fumio  

Journal of Gastroenterology, Vol. 41, Iss. 12, 2006-12 ,pp. : 1231-1236

Springer Publishing Company

Access to resources Recommend Favorite